Dermatological side effects of epidermal growth factor receptor inhibitors: 'Pride' complex

• Ngā kaituhi matua: Bhushan Madke (Author), Prachi Gole (Author), Prabhash Kumar (Author), Uday Khopkar (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Epidermal growth factor receptor (EGFR) inhibitor therapy has become the standard treatment for non-small cell lung cancer and head neck malignancy. This class of drug comprises EGFR inhibitors (erlotinib and gefitinib) and monoclonal antibody (cetuximab). Use of this class of drugs has been associa...